Η σελίδα απευθύνεται μόνο σε επαγγελματίες υγείας
◊ Diabetes Care (ADA) Review: The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 Diabetes ➥ Free
◊ ADA Statement 2025 – Compounded GLP-1 and Dual GIP/GLP-1 Receptor Agonists ➥ Free
◊ ΕΔΕ 2025 – Οι νέες κατευθυντήριες οδηγίες για το διαβήτη ➥ Free
◊ 2025 Οι νέες οδηγίες και συστάσεις για το διαβήτη από την American Diabetes Association, (ADA) 2025 ➥ Free
◊ EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary. Diabetologia 67, 2375–2392 (2024). https://doi.org/10.1007/s00125-024-06196-3 ➥ Open Access
◊ The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: A position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD) 2024 ➥ Open Access
◊ Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Diabetes Care October 2023 ➥ Free
◊ International Diabetes Federation (IDF): Policy Brief – Obesity and Type 2 Diabetes: a Joint Approach to Halt the Rise (as pdf file) ➥ | Position Statement – Prevention of obesity and type 2 diabetes in the school environment (as pdf file) ➥ Free
Βιβλιογραφία – Επιλογές άρθρων
- Rubino, Francesco et al. Definition and diagnostic criteria of clinical obesity, The Lancet Diabetes & Endocrinology, Volume 0, Issue 0, DOI: 10.1016/S2213-8587(24)00316-4 ➥ | (24/01/2025: EASO response ➥)
- et al. Intensive Blood-Pressure Control in Patients with Type 2 Diabetes (BPROAD ClinicalTrials.gov), NEJM, November 16, 2024, DOI: 10.1056/NEJMoa2412006 ➥
- , et al. Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity (SUMMIT ClinicalTrials.gov), NEJM, November 16, 2024, DOI: 10.1056/NEJMoa2410027 ➥
- et al. Tirzepatide for Obesity Treatment and Diabetes Prevention (SURMOUNT-1 ClinicalTrials.gov), NEJM, November 13, 2024, DOI: 10.1056/NEJMoa2410819 ➥
- Santoso, C., Wei, Y., Ahlqvist, E. et al. Autoimmune diseases and the risk and prognosis of latent autoimmune diabetes in adults. Diabetologia (2024). https://doi.org/10.1007/s00125-024-06303-4 ➥
- Byndloss, M., Devkota, S., Duca, F. et al. The gut microbiota and diabetes: research, translation, and clinical applications – 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum. Diabetologia 67, 1760–1782 (2024). https://doi.org/10.1007/s00125-024-06198-1 ➥
- M. N. Ahmadi, et al., Relationship of device measured physical activity type and posture with cardiometabolic health markers: pooled dose–response associations from the Prospective Physical Activity, Sitting and Sleep Consortium, Diabetologia (2024). https://doi.org/10.1007/s00125-024-06090-y ➥
Συνέδρια
- IDF World Diabetes Congress 2025, 7-10 April 2025, Bangkok, Thailand
- 85th Scientific Sessions American Diabetes Association (ADA) – McCormick Place Convention Center, Chicago, IL, USA, June 20–23, 2025
- 61st Annual Meeting of European Association for the Study of Diabetes (EASD), Vienna – Austria, 15 – 19 September 2024
- 28ο Πανελλήνιο Συνέδριο Εσωτερικής Παθολογίας από την Ελληνική Εταιρεία Εσωτ. Παθολογίας (ΕΕΕΠ), 24 – 27/9/2025, Μέγαρο Μουσικής Αθήνα, ανακοίνωση | Υποβολή εργασιών ως 30/06/2025 ➥
- 62nd Annual Meeting of European Association for the Study of Diabetes (EASD), Milan – Italy, 28 September – 02 October 2026
- 19th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD), Barcelona – Spain, 11 – 14 March 2026
- 86th Scientific Sessions American Diabetes Association (ADA) – Ernest N. Morial Convention Center, New Orleans, LA, USA, June 5–8, 2026
Ανασκοπήσεις – Διαδραστικά – Online First Articles – Αντιπαραθέσεις
NEJM Original Article: Liraglutide for Children 6 to <12 Years of Age with Obesity — A Randomized Trial | Quick Take Video (02:01 min) ➥ Free
Citation: https://www.nejm.org/doi/full/10.1056/NEJMoa2407379
NEJM Original Article: Tirzepatide for Obesity Treatment and Diabetes Prevention SURMOUNT-1 Trial | Quick Take Video (02:27 min) ➥
Citation: https://www.nejm.org/doi/full/10.1056/NEJMoa2410819
NEJM Original Article: Tirzepatide for Heart Failure in Patients with Obesity | Quick Take Video ➥ (02:43 min) Free
Citation: https://www.nejm.org/do/10.1056/NEJMdo007849/full/
Diabetes Care: Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials ➥ Free
Citation: https://doi.org/10.2337/dc24-1678
ADA – Diabetes Care: TOBOGM-Study (Treatment of Booking Gestational Diabetes Mellitus) | Collection of Articles ➥ Free
Debate: Katherine E. Griffin; Use of SGLT2i Versus DPP-4i as an Add-On Therapy and the Risk of PAD-Related Surgical Events (Amputation, Stent Placement, or Vascular Surgery): A Cohort Study in Veterans With Diabetes. Diabetes Care 2024; dc241546. https://doi.org/10.2337/dc24-1546 ➥
vs
Meng PanTil Stürmer; Sodium–Glucose Cotransporter 2 Inhibitors and Lower-Extremity Amputation: Is the Guilty Verdict Valid?. Diabetes Care 2025; dci240101. https://doi.org/10.2337/dci24-0101 ➥
Public Library of Science (PLOS)
PLOS is a nonprofit, open access publisher empowering researchers to accelerate progress in science and medicine by leading a transformation in research communication. ➥
- PLOS – Medicine Journal ➥
- PLOS Blog – Speaking of Medicine and Health ➥
Τελευταία ενημέρωση: 13/04/2025